| C09CA08 |
Olmesartan medoxomil |
Olsart |
Film coated tablet |
10 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
20 |
mg |
- |
12.71 |
0.25033 |
3.75 |
25% |
0.93 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11685/10.02.2017; НСР-15506/26.04.2018 |
02.09.2018 |
|
|
Активен |
15602 |
| C09CA08 |
Olmesartan medoxomil |
Tansidor |
Film coated tablet |
40 |
mg |
28 |
Sandoz d.d., Словения |
20 |
mg |
- |
83.82 |
0.25033 |
14.02 |
25% |
3.5 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-10567/12.10.2016; КП-23/02.04.2018 и НСР-14829/18.01.2018; АССГ-4718/10.07.2018; КП-70/17.09.2018 и НСР-14829/18.01.2018; ВАС-2364/13.02.2020 |
02.03.2020 |
|
|
Активен |
15439 |
| C09CA08 |
Olmesartan medoxomil |
Tansidor |
Film coated tablet |
20 |
mg |
28 |
Sandoz d.d., Словения |
20 |
mg |
- |
43.31 |
0.25033 |
7.01 |
25% |
1.75 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-10566/12.10.2016; КП-22/02.04.2018 и НСР-14828/18.01.2018; ВАС-13228/08.10.2019, АССГ-6318/01.11.2018 и НСР-10566/12.10.2016 |
02.02.2020 |
|
|
Активен |
15440 |
| C09CA08 |
Olmesartan medoxomil |
Tensar |
Film coated tablet |
40 |
mg |
28 |
Menarini International Operations Luxembourg S.A., Люксембург |
20 |
mg |
- |
19.87 |
0.25033 |
14.02 |
25% |
3.5 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-19324/26.07.2019; НСР-20244/28.11.2019 предварително изпълнение |
02.12.2019 |
|
|
Активен |
16644 |
| C09CA08 |
Olmesartan medoxomil |
Tensar |
Film coated tablet |
20 |
mg |
28 |
Menarini International Operations Luxembourg S.A., Люксембург |
20 |
mg |
- |
17.93 |
0.25033 |
7.01 |
25% |
1.75 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-1625/01.11.2013; НСР-1785/21.11.2013; НСР-5387/07.01.2015; НСР-8431/07.03.2016; НСР-12661/12.05.2017; НСР-16020/29.06.2018 |
02.09.2018 |
|
|
Активен |
3484 |
| C09CA08 |
Olmesartan 100% |
C09CA08 Olmesartan 100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09CA08 |
Olmesartan medoxomil |
Olmesta |
Film coated tablet |
40 |
mg |
30 |
Teva B.V., Нидерландия |
20 |
mg |
12.84 |
- |
0.214 |
12.84 |
100% |
12.84 |
|
I10 |
HCP-8941/13.04.2016; КП-22/20.04.2017 и НСР-11766/17.02.2017; ВАС № 5852/08.05.2018, АССГ № 5100/02.08.2017 и КП-46/19.06.2018; НСР-16483/17.08.2018; НСР-17171/09.11.2018 |
02.08.2019 |
|
|
Активен |
1486 |
| C09CA08 |
Olmesartan medoxomil |
Olmesta |
Film coated tablet |
20 |
mg |
30 |
Teva B.V., Нидерландия |
20 |
mg |
12.84 |
- |
0.214 |
6.42 |
100% |
6.42 |
|
I10 |
HCP-8941/13.04.2016; КП-21/20.04.2017 и НСР-11768/17.02.2017; ВАС № 4319/03.04.2018 г., АССГ- 6613/13.11.2017 и КП-47/19.06.2018 г.; НСР-16484/17.08.2018; НСР-17169/09.11.2018 |
02.08.2019 |
|
|
Активен |
1485 |
| C09CA08 |
Olmesartan medoxomil |
Olmezide |
Film coated tablet |
40 |
mg |
30 |
Stada Arzneimittel AG, Германия |
20 |
mg |
13.19 |
- |
0.214 |
12.84 |
100% |
12.84 |
|
I10 |
НСР-19724/04.09.2019 |
02.10.2019 |
|
|
Активен |
16689 |
| C09CA08 |
Olmesartan medoxomil |
Olmezide |
Film coated tablet |
20 |
mg |
30 |
Stada Arzneimittel AG, Германия |
20 |
mg |
12.8 |
- |
0.214 |
6.42 |
100% |
6.42 |
|
I10 |
НСР-19724/04.09.2019 |
02.10.2019 |
|
|
Активен |
16688 |
| C09CA08 |
Olmesartan medoxomil |
Olsart |
Film coated tablet |
40 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
20 |
mg |
50.36 |
- |
0.214 |
12.84 |
100% |
12.84 |
|
I10 |
НСР-10656/21.10.2016; НСР-17717/10.01.2019. |
02.08.2019 |
|
|
Активен |
15452 |
| C09CA08 |
Olmesartan medoxomil |
Olsart |
Film coated tablet |
20 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
20 |
mg |
25.67 |
- |
0.214 |
6.42 |
100% |
6.42 |
|
I10 |
НСР-10655/21.10.2016; НСР-17715/10.01.2019. |
02.08.2019 |
|
|
Активен |
15451 |
| C09CA08 |
Olmesartan medoxomil |
Olsart |
Film coated tablet |
10 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
20 |
mg |
10.7 |
- |
0.214 |
3.21 |
100% |
3.21 |
|
I10 |
НСР-11685/10.02.201; НСР-15506/26.04.2018 |
02.08.2019 |
|
|
Активен |
15602 |
| C09CA08 |
Olmesartan medoxomil |
Tansidor |
Film coated tablet |
40 |
mg |
28 |
Sandoz d.d., Словения |
20 |
mg |
72.65 |
- |
0.214 |
11.98 |
100% |
11.98 |
|
I10 |
НСР-10567/12.10.2016; КП-23/02.04.2018 и НСР-14829/18.01.2018.; АССГ-4718/10.07.2018; КП-70/17.09.2018 и НСР-14829/18.01.2018.; ВАС-2364/13.02.2020 |
02.03.2020 |
|
|
Активен |
15439 |
| C09CA08 |
Olmesartan medoxomil |
Tansidor |
Film coated tablet |
20 |
mg |
28 |
Sandoz d.d., Словения |
20 |
mg |
37.02 |
- |
0.214 |
5.99 |
100% |
5.99 |
|
I10 |
НСР-10566/12.10.2016; КП-22/02.04.2018 и НСР-14828/18.01.2018.; ВАС-13228/08.10.2019, АССГ-6318/01.11.2018 и НСР-10566/12.10.2016 |
02.02.2020 |
|
|
Активен |
15440 |
| C09CA08 |
Olmesartan medoxomil |
Tensar |
Film coated tablet |
40 |
mg |
28 |
Menarini International Operations Luxembourg S.A., Люксембург |
20 |
mg |
16.99 |
- |
0.214 |
11.98 |
100% |
11.98 |
|
I10 |
НСР-19324/26.07.2019; НСР-20244/28.11.2019 предварително изпълнение |
02.12.2019 |
|
|
Активен |
16644 |
| C09CA08 |
Olmesartan medoxomil |
Tensar |
Film coated tablet |
20 |
mg |
28 |
Menarini International Operations Luxembourg S.A., Люксембург |
20 |
mg |
15.32 |
- |
0.214 |
5.99 |
100% |
5.99 |
|
I10 |
HCP-8942/13.04.2016; НСР-12661/12.05.2017; НСР-16020/29.06.2018. |
02.08.2019 |
|
|
Активен |
3484 |
| C09DA01 |
Losartan; Hydrochlorothiazide |
C09DA01 Losartan; Hydrochlorothiazide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09DA01 |
Losartan, Hydrochlorithiazide |
CO-HYPERTONIC |
Film coated tablet |
50 mg/12,5 mg |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
1 |
tabl |
- |
11.3 |
0.19714 |
5.91 |
50% |
2.95 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 208/ 04.11.2011; НСР-18345/05.04.2019 |
02.09.2019 |
08.09.2012 |
|
Активен |
1084 |
| C09DA01 |
Losartan, Hydrochlorithiazide |
LORISTA H |
Film coated tablet |
50 mg/12,5 mg |
|
28 |
KRKA, d.d., Словения |
1 |
tabl |
- |
5.58 |
0.19714 |
5.52 |
50% |
2.76 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 53/ 24.02.2010; № 67/ 08.04.2010; НСР-1154/13.09.2013; НСР-5141/27.11.2014 |
02.09.2019 |
08.09.2012 |
|
Активен |
3411 |
| C09DA01 |
Losartan, Hydrochlorithiazide |
LORISTA HD |
Film coated tablet |
100 mg/ 25 mg |
|
28 |
KRKA, d.d., Словения |
1 |
tabl |
- |
8.14 |
0.29071 |
8.14 |
50% |
4.07 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-894/09.08.2013 |
02.07.2016 |
08.09.2012 |
|
Активен |
2062 |
| C09DA01 |
Losartan, Hydrochlorithiazide |
Lorista HL |
Film coated tablet |
100 mg/12,5 |
|
30 |
KRKA, d.d., Словения |
1 |
tabl |
- |
9.83 |
0.31053 |
9.32 |
50% |
4.66 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 179/ 22.06.2011.; НСР-6933/12.08.2015.; НСР-14228/19.10.2017 |
02.12.2017 |
08.09.2012 |
|
Активен |
1041 |
| C09DA01 |
Losartan, Hydrochlorithiazide |
Losarcon-Co |
Film coated tablet |
50 mg/12.5 mg |
mg |
30 |
Фармаконс АД, България |
1 |
tabl |
- |
15.24 |
0.19714 |
5.91 |
50% |
2.95 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-13732/12.09.2017 |
02.09.2019 |
|
|
Активен |
15837 |
| C09DA01 |
Losartan, Hydrochlorithiazide |
Lozap H |
Film coated tablet |
50 mg/12.5 mg |
mg |
30 |
Zentiva k.s., Чешка република |
1 |
tabl |
- |
10.44 |
0.19714 |
5.91 |
50% |
2.95 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 67/ 08.04.2010; КЦРР-2730/20.03.2013 г. |
02.09.2019 |
08.09.2012 |
|
Активен |
1381 |
| C09DA01 |
Losartan, Hydrochlorithiazide |
RASOLTAN PLUS |
Film coated tablet |
50 mg/12,5 mg |
|
30 |
Actavis Group PTC ehf., Исландия |
1 |
tabl |
- |
8.94 |
0.19714 |
5.91 |
50% |
2.95 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 172/ 31.05.2011; № 176/ 21.06.2011; КЦРР-701/05.06.2012 г.; НСР-4442/15.08.2014 и КП-94/06.04.2015.; НСР-19261/18.07.2019 |
02.09.2019 |
08.09.2012 |
|
Активен |
3758 |